Skip to main content
. 2018 Apr 13;9(28):19817–19825. doi: 10.18632/oncotarget.24865

Figure 1. Success rate of multiplex next-generation sequencing (NGS) assay in 30 consecutive patients with pancreatic cancer.

Figure 1